# Efficacy and Safety of Four Escalating Dose Regimens of TPI ASM8 in Patients With Allergic Asthma

> **NCT00822861** · PHASE2 · COMPLETED · sponsor: **Syntara** · enrollment: 14 (actual)

## Conditions studied

- Asthma

## Interventions

- **DRUG:** TPI ASM8
- **DRUG:** TPI ASM8
- **DRUG:** TPI ASM8
- **DRUG:** TPI ASM8

## Key facts

- **NCT ID:** NCT00822861
- **Lead sponsor:** Syntara
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-04
- **Primary completion:** 2010-02
- **Final completion:** 2010-02
- **Target enrollment:** 14 (ACTUAL)
- **Last updated:** 2013-11-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00822861

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00822861, "Efficacy and Safety of Four Escalating Dose Regimens of TPI ASM8 in Patients With Allergic Asthma". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00822861. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*